Express Pharma
Home  »  Latest Updates  »  Sun Pharma issues voluntary nationwide recall of Riomet

Sun Pharma issues voluntary nationwide recall of Riomet

17

Riomet was found to be contaminated

Sun Pharmaceutical Industries, Inc. (SPII), a wholly owned subsidiary of Sun Pharmaceutical Industries is voluntarily recalling two lots of Riomet (Metformin Hydrochloride Oral Solution), 500 mg/5mL, to the retail level (Class II Recall). This product is manufactured for SPII by a contract manufacturer. The Riomet (Metformin Hydrochloride Oral Solution) has been found to be contaminated (Scopulariopsis brevicaulis). The contamination was discovered during sample preparation for the Antimicrobial Preservative Effectiveness Testing (AMPET) being performed as part of the 12 month stability study interval.

Use of Riomet (Metformin Hydrochloride Oral Solution) potentially could result in a risk of infection, especially in the immunocompromised patient. The most plausible portal of entry of Scopulariopsis brevicaulis is the respiratory tract, where it may cause pneumonia, sinusitis and disseminated infections. To date, SPII has not received any reports of adverse events related to this recall.

Riomet (Metformin Hydrochloride Oral Solution) is indicated to treat type II diabetes mellitus in adult and children age 10 and above. Riomet is packaged in 118 mL (4 fl. oz.) and 473 mL (16 fl. oz.) bottles. The affected Riomet (Metformin Hydrochloride Oral Solution) includes product with NDC Code 10631-206-01 Lot A160031A, Exp.: 01/2018, and NDC 10631-206-02 Lot: A160031B, Exp.: 01/2018. The product can be identified by its bottle labelled as Riomet (Metformin Hydrochloride Oral Solution) containing the specific Lot and Exp. dates mentioned above. This product was distributed nationwide to wholesale customers.

Comments are closed.